Categories: News

VivaLNK Selected to Plug and Play’s Silicon Valley Health Batch 8 Program

CAMPBELL, Calif., April 4, 2019 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, has been selected to participate in Plug & Play’s Silicon Valley Health Batch 8 Program lasting 12 weeks.

Plug and Play, a leading Global Innovation Platform, operates industry specific, stage-agnostic platforms that help startups and growth-stage companies raise funding and pursue business development opportunities in collaboration with corporations. Through the development of a world-class ecosystem, Plug and Play provides entrepreneurs with opportunities to succeed through guidance from local startups, growth-stage companies, investors, mentors, and Fortune 500 corporations.

The Health Batch 8 program is designed to connect innovative healthcare technology and solution companies with corporate partners to disrupt the healthcare industry by challenging clinical practices, improving data analytics, and enhancing the patient journey across the care continuum.

“We’re very proud to be among only 20 companies selected from more than 850 candidates to participate in the Health Batch 8 program,” said Jiang Li, CEO of VivaLNK. “With our unique Medical IoT Sensor platform, we look forward to engaging with customers, partners and investors to accelerate and promote healthcare innovation throughout the world.”

For information about VivaLNK, visit: www.vivalnk.com.
For information about Plug and Play, visit: www.plugandplaytechcenter.com.

About VivaLNK
VivaLNK is a provider of connected healthcare solutions for wellness, patient care, and telemedicine. The company’s portfolio includes wearable medical grade devices and data analytics applications that continuously monitor the health and well-being of individuals. The company’s vision is to improve the quality and accessibility of healthcare worldwide by combining technology, data, and analytics into an integrated solution.

Media Contact:
pr@VivaLNK.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/vivalnk-selected-to-plug-and-plays-silicon-valley-health-batch-8-program-300824536.html

SOURCE VivaLNK

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

35 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

36 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

40 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

40 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

40 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

40 minutes ago